Concepedia

Author

Elina Berliba

Chulalongkorn UniversityORCID

Also Known As

Berliba, E.T., E Berliba, E. Berliba, Elina Berliba

32

Publications

425

Citations

9

H-Index

16

Concepts

All Affiliations

Chulalongkorn UniversityNicolae Testemițanu State University of Medicine and PharmacyUniversity of California San DiegoDelta Air Lines (United States)Clinical Trials New Zealand
EB

About

Elina Berliba is an author at Chulalongkorn University specializing in medicine, hematology, and clinical microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

40

2

Gastroenterology

1

1

19

3

Immunology

1

1

19

4

Pathology

1

1

19

5

Pharmacology

1

1

11

Elina Berliba

×

9

Publications

407

Citations

9

H-Index

YearCitations

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari,

Gastroenterology

2019

216

Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari,

Clinical Gastroenterology and Hepatology

2020

60

Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis

Elina Berliba, Maxim Bogus, Frédéric Vanhoutte,

Antimicrobial Agents and Chemotherapy

2019

39

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B

Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen,

Hepatology Communications

2022

26

882 - Efficacy and Safety of Anti-Interleukin-23 Therapy with Mirikizumab (LY3074828) in Patients with Moderate-To-Severe Ulcerative Colitis in a Phase 2 Study

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari,

Gastroenterology

2018

19

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection

Ed Gane, Christian Schwabe, Elina Berliba,

Journal of Antimicrobial Chemotherapy

2021

14

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects

Matthew W. McClure, Elina Berliba, Tengiz Tsertsvadze,

PLoS ONE

2018

12

A combination of AT-527, a pan-genotypic guanosine nucleotide prodrug, and daclatasvir was well-tolerated and effective in HCV-infected subjects

Ounisha Mungur, Elina Berliba, Stefan Bourgeois,

Journal of Hepatology

2020

11

Long-term suppression maintained after cessation of AB-729 treatment and comparable on-treatment response observed in HBeAg+ subjects

Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen,

Journal of Hepatology

2022

10

Page 1